High-performance liquid chromatographic determination of vinorelbine in human plasma and blood: application to a pharmacokinetic study.

[1]  C. Vogel,et al.  Vinorelbine as first-line chemotherapy for advanced breast cancer in women 60 years of age or older. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  D. Levêque,et al.  Clinical Pharmacokinetics of Vinorelbine , 1996, Clinical pharmacokinetics.

[3]  B. Weber,et al.  Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  T. Delozier,et al.  Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Quoix,et al.  Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography. , 1991, Cancer research.

[6]  M. Morimoto,et al.  Experimental antitumor activity of Navelbine. , 1989, Seminars in oncology.

[7]  J. Barbet,et al.  Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine). , 1987, Cancer research.

[8]  J. Gabrilove,et al.  Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center. , 1989, Seminars in oncology.